A distinctive IgG-mediated pathogenesis for primary progressive multiple sclerosis?

Brain. 2023 May 2;146(5):1737-1739. doi: 10.1093/brain/awad107.

Authors

Yong Guo^{1

2}, Vanda A Lennon^{1

2

3

4}

Affiliations

¹ Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
² Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN 55905, USA.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
⁴ Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.

PMID: 37006119
DOI: 10.1093/brain/awad107

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Immunoglobulin G
Multiple Sclerosis* / cerebrospinal fluid
Multiple Sclerosis, Chronic Progressive* / cerebrospinal fluid
Multiple Sclerosis, Relapsing-Remitting* / cerebrospinal fluid

Substances

Immunoglobulin G

Grants and funding

R01 NS110949/NS/NINDS NIH HHS/United States